SINOMED(SH:688108) Sou Hu Cai Jing·2025-08-13 06:39Core Viewpoint - Sino Medical achieved a significant stock price increase of 19.99%, reaching 30.13 CNY per share, with a trading volume of 3.005 billion CNY and a turnover rate of 26.34%, resulting in a total market capitalization of 12.536 billion CNY [1] Company Overview - Sino Medical Science and Technology Co., Ltd. is located in Tianjin Development Zone and specializes in the research, production, and sales of high-end interventional medical devices [1] - The company’s main products include coronary drug-eluting stents, coronary balloons, intracranial rapid exchange balloons, and intracranial drug-eluting stents, with over 1.4 million units used globally, serving hundreds of thousands of patients [1] - Sino Medical holds 8 key technologies, has launched 19 products, and possesses over 200 global patents, while undertaking 7 national and provincial scientific research projects [1] - Clinical research results have been published in 31 articles in core domestic and international journals [1] Financial Performance - For the first quarter of 2025, Sino Medical reported a revenue of 101 million CNY, representing a year-on-year growth of 10.75% [1] - The net profit attributable to shareholders was 2.9693 million CNY, showing a substantial year-on-year increase of 277.50% [1] - As of March 31, the number of shareholders was 11,000, with an average of 37,400 circulating shares per person [1]